Innovation Pharmaceuticals Inc (IPIX)

[frenchbroad]

The title of this new article says a lot.
https://fortune.com/well/2022/09/24/new-covid-omicron-variants-subvariants-evade-monoclonal-antibodies-bebtelovimab-recombinants-convergent-evolution-sars-immune-evasion/
"It’s a concerning pattern that has the ability to reduce the effectiveness of COVID treatments, as acknowledged by World Health Organization officials this week—and perhaps even vaccines. In a worst-case scenario, increasingly immune-evasive variants could render them ineffective entirely."

Of course this is not a surprise. This from 1.5 years before:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=163071040

A broad spectrum anti-viral that can kill any of the new viruses before they have the chance to attack can be super useful. And valuable.